203 related articles for article (PubMed ID: 2767134)
1. Cardiac and hemodynamic profile of the new cardiotonic agent, DPI 201-106, in the conscious dog.
Gerard JL; Berdeaux A; Giudicelli JF
Eur J Pharmacol; 1989 Jun; 165(1):39-49. PubMed ID: 2767134
[TBL] [Abstract][Full Text] [Related]
2. Compared peripheral vascular responses to intravenous and intra-arterial administrations of positive inotropic agents in conscious dogs.
Gosgnach M; Gérard JL; Berdeaux A; Giudicelli JF
Fundam Clin Pharmacol; 1991; 5(8):709-18. PubMed ID: 1783360
[TBL] [Abstract][Full Text] [Related]
3. Effects of DPI 201-106, a novel cardiotonic agent, on hemodynamics, cardiac electrophysiology and arrhythmias induced by programmed ventricular stimulation in dogs with subacute myocardial infarction: a comparative study with dobutamine.
Ozaki T; Uematsu T; Nagashima S; Nishimoto M; Nakashima M
Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):478-87. PubMed ID: 1766473
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 2nd communication: studies in dogs.
Ohhara H; Ogawa T; Takeda M; Katoh H; Daiku Y; Igarashi T
Arzneimittelforschung; 1989 Jan; 39(1):38-45. PubMed ID: 2719742
[TBL] [Abstract][Full Text] [Related]
5. Effects of a novel inotropic agent, BAY y 5959, in conscious dogs: comparison with dobutamine and milrinone.
Sato N; Uechi M; Asai K; Patrick T; Kudej RK; Vatner SF
Am J Physiol; 1997 Feb; 272(2 Pt 2):H753-9. PubMed ID: 9124435
[TBL] [Abstract][Full Text] [Related]
6. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
[TBL] [Abstract][Full Text] [Related]
7. Cardiac and hemodynamic effects of S(-)- and (R(+)-DPI 201-106 and of racemic DPI 201-106 in conscious dogs.
Gérard JL; Berdeaux A; Giudicelli JF
Eur J Pharmacol; 1990 Aug; 184(2-3):321-3. PubMed ID: 2079100
[TBL] [Abstract][Full Text] [Related]
8. Effects of milrinone on systemic hemodynamics and regional circulations in dogs with congestive heart failure: comparison with dobutamine.
Liang CS; Thomas A; Imai N; Stone CK; Kawashima S; Hood WB
J Cardiovasc Pharmacol; 1987 Nov; 10(5):509-16. PubMed ID: 2447398
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of inotropic agents on coronary and systemic hemodynamics of conscious dogs: actions of milrinone, dopamine, ouabain and MCI-154.
Al-Wathiqui MH; Shimshak TM; Brooks HL; Preuss KC; Wynsen JC; Gross GJ; Warltier DC
Pharmacology; 1988; 36(4):217-27. PubMed ID: 3380877
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the inotropic and arrhythmogenic action of the sodium channel activator BDF 9148: a comparison to its S-enantiomer BDF 9196, to its congener DPI 201-106, to norepinephrine, and to ouabain.
Baumgart D; Ehring T; Krajcar M; Skyschally A; Heusch G
Basic Res Cardiol; 1994; 89(1):61-79. PubMed ID: 8010937
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular effects and plasma levels of denopamine (TA-064), a new positive inotropic agent, in chronically instrumented dogs.
Ikeo T; Nagao T; Suzuki T; Yabana H; Nakajima H
Jpn J Pharmacol; 1985 Oct; 39(2):191-9. PubMed ID: 4087566
[TBL] [Abstract][Full Text] [Related]
12. Comparison of positive inotropic effects of milrinone, dobutamine and ouabain.
Rendig SV; Amsterdam EA
Cardiology; 1994; 84(2):99-105. PubMed ID: 8174147
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular actions of DPI 201-106, a novel cardiotonic agent.
Salzmann R; Scholtysik G; Clark B; Berthold R
J Cardiovasc Pharmacol; 1986; 8(5):1035-43. PubMed ID: 2429077
[TBL] [Abstract][Full Text] [Related]
14. Influence of acidosis on cardiotonic effects of milrinone.
Tanaka M; Ishikawa T; Nishikawa T; Goto K; Sato S
Anesthesiology; 1998 Mar; 88(3):725-34. PubMed ID: 9523817
[TBL] [Abstract][Full Text] [Related]
15. Increases in inotropic state without change in heart rate: combined use of dobutamine and zatebradine in conscious dogs.
Hettrick DA; Pagel PS; Lowe D; Tessmer JP; Warltier DC
Eur J Pharmacol; 1996 Dec; 316(2-3):237-44. PubMed ID: 8982692
[TBL] [Abstract][Full Text] [Related]
16. Combined inotropic and bradycardic effects of a sodium channel enhancer in conscious dogs with heart failure: a mechanism for improved myocardial efficiency compared with dobutamine.
Shen W; Gill RM; Jones BD; Zhang JP; Corbly AK; Steinberg MI
J Pharmacol Exp Ther; 2002 Nov; 303(2):673-80. PubMed ID: 12388650
[TBL] [Abstract][Full Text] [Related]
17. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
Jaski BE; Fifer MA; Wright RF; Braunwald E; Colucci WS
J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022
[TBL] [Abstract][Full Text] [Related]
18. Interaction of DPI 201-106 with cardiac glycosides.
Scholtysik G; Salzmann R; Gerber W
J Cardiovasc Pharmacol; 1989 Feb; 13(2):342-7. PubMed ID: 2468968
[TBL] [Abstract][Full Text] [Related]
19. The inotropic and hemodynamic effects of intravenous milrinone when reflex adrenergic stimulation is suppressed by beta-adrenergic blockade.
Travill CM; Pugh S; Noble MI
Clin Ther; 1994; 16(5):783-92. PubMed ID: 7859237
[TBL] [Abstract][Full Text] [Related]
20. [Effects of recombinant human brain natriuretic peptide and milrinone on cardiac hemodynamics and renal function in anesthetized dog].
Xu XW; Yang W; Zhao ZY; Liu HX; Zeng GY
Yao Xue Xue Bao; 2002 Jul; 37(7):506-9. PubMed ID: 12914318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
